Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AGRP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP6V0D1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSD11B2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM65A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TPPP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTCF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRC36 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARD6A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GFOD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC9A5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FHOD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM208 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ELMO3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RANBP10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
E2F4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on